Skip to main content

Table 1 Baseline characteristics of rheumatoid arthritis patients treated with adalimumab a

From: Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis

Characteristics Data
Gender (% women) 92.8
Mean age (±SD), yr 56.6 ± 13.6
Mean disease duration (±SD), yr 13.8 ± 11.2
Mean RF + and/or ACPA + (%) 78.6
Mean concomitant methotrexate (%) 64.3
Mean concomitant prednisone (%) 64.3
Mean previous DMARDs, number (range) 3.07 (1 to 5)
Mean ESR, mm/h (±SD) 40.1 ± 23.6
Mean CRP, mg/L (±SD) 15.6 ± 17.8
Mean DAS28-ESR, IU (±SD) 5.05 ± 0.95
  1. aACPA Anticitrullinated peptide antibodies; CRP, C-reactive protein; DAS28-ESR, Disease Activity Score in 28 joints erythrocyte sedimentation rate; DMARDs, Disease-modifying arthritis drugs; RF, Rheumatoid factor.